Nataly Manjarrez Orduño

Nataly Manjarrez Orduño

Bristol-Myers Squibb Co. - New York / United States
Others
AD Scientific Index ID: 4388137
-
person_outline Nataly Manjarrez Orduño's MOST POPULAR ARTICLES
1-) Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgMTD Quách, N Manjarrez-Orduño, DG Adlowitz, L Silver, H Yang, C Wei, ...The Journal of Immunology 186 (8), 4640-4648, 20111312011
2-) Early type I interferon‐mediated signals on B cells specifically enhance antiviral humoral responsesK Fink, KS Lang, N Manjarrez‐Orduno, T Junt, BM Senn, M Holdener, ...European journal of immunology 36 (8), 2094-2105, 20061292006
3-) CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activationN Manjarrez-Orduño, E Marasco, SA Chung, MS Katz, JF Kiridly, ...Nature genetics 44 (11), 1227-1230, 20121182012
4-) Circulating T cell subpopulations correlate with immune responses at the tumor site and clinical response to PD1 inhibition in non-small cell lung cancerN Manjarrez-Orduño, LC Menard, S Kansal, P Fischer, B Kakrecha, ...Frontiers in immunology 9, 1613, 20181182018
5-) B cells and immunological toleranceN Manjarrez-Orduño, TD Quách, I SanzJournal of investigative dermatology 129 (2), 278-288, 2009872009